Product Profiles Systemic Lupus Erythematosus %E2%80%93 Benlysta approval brings lessons and hope to market

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

  • $ 645
  • Industry report
  • by Firstword Pharma
  • Dec 2014

The potential blockbuster status of Novartis' LCZ696 has seemingly been cemented in the eyes of the Street thanks to solid results from the Phase III PARADIGM-HF study that were presented over the weekend. Indeed, the chronic heart failure agent is believed to represent both a significant growth drive ...

Industries: Pathology | Countries: United States

Medical Industry Week 15 DECEMBER 2014

Medical Industry Week 15 DECEMBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • December 2014
  • 24 pages

Industry Trend Analysis - Medical Devices - 2014 Industry Trends Industry Brief - 3M Settles Latest Dental Ceramic Colouring Patent Suit With Licence Deal Industry Brief - Milestone Scientific Signs Deal For Epidural Instrument In China Industry Brief - SDRI/Joimax Sign Distribution Deal For Synergy ...

Industries: Pathology | Countries: United States, Canada, China

Medical Industry Week 08 DECEMBER 2014

Medical Industry Week 08 DECEMBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • December 2014
  • 24 pages

Industry Trend Analysis - Increasing Diabetic Burden Will Nurture Appeal For RETeval Retinopathy Diagnostic Industry Brief - Nihon Kohden/Neuralynx Enter Partnership For Clinical Electroencephalography Research Industry Brief - Orthocell And BoneSupport Combine Technologies To Create New Bone Repai ...

Industries: Pathology | Countries: United States

Orion Genomics LLC - Product Pipeline Analysis, 2014 Update

Orion Genomics LLC - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • by Global Data
  • December 2014
  • 31 pages

Summary Orion Genomics LLC (Orion Genomics) is a provider of epigenetic research tools and molecular diagnostic products. Its products include colon cancer risk test, bladder cancer screening and lung cancer screening system, and biomarker. Orion Genomics offers diagnostic test products for breast, lung, ...

Industries: Pathology | Countries: United States

Vitatex Inc. - Product Pipeline Analysis, 2014 Update

Vitatex Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • by Global Data
  • December 2014
  • 22 pages

Summary Vitatex Inc. (Vitatex) is a biotechnology company. The company research and develops new immunochemistry assays and reagents for the in-vitro diagnostic market. Its research products include Vita-Assays, Vita-Cap, tumor angiogenesis and metastasis monoclonal antibodies. Vitatex's Vita-Cap is ...

Industries: Pathology | Countries: United States

ProCelo AS - Product Pipeline Analysis, 2014 Update

ProCelo AS - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • by Global Data
  • December 2014
  • 26 pages

Summary ProCelo AS (ProCelo) is a medical device company. The company develops and markets diagnostic assays for detection of bacterial infections. Its ProCt product is a diagnostic kit which is used for detection of chlamydia trachomatis. The company's product, ProCt serves the US and Asian markets ...

Industries: Pathology | Countries: United States, Norway

Biocept, Inc. (BIOC) - Product Pipeline Analysis, 2014 Update

Biocept, Inc. (BIOC) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • by Global Data
  • December 2014
  • 31 pages

Summary Biocept, Inc. (Biocept) is a diagnostics service provider. The company provides molecular oncology laboratory services. Its services include prognostic CTC enumeration for various solid tumors, levels of sensitivity to detect CTCs, and molecular testing on CTCs. Biocept offers tests to various ...

Industries: Pathology | Countries: United States

UV Flu Technologies Incorporation

UV Flu Technologies Incorporation

  • $ 55
  • Company report
  • by Wright Investors' Service
  • December 2014
  • 52 pages

A textual analysis of the financial results for UV Flu Technologies Incorporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A ...

Industries: Pathology | Countries: United States

Array BioPharma Inc. (Symbol:ARRY) SWOT Analysis, Strategy, Revenues and Profits

Array BioPharma Inc. (Symbol:ARRY) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • December 2014
  • 54 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Array BioPharma Inc. SWOT Analysis report provides you a strategic ...

Industries: Pathology | Countries: United States

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8 119
  • Industry report
  • by Firstword Pharma
  • December 2014

The Ulcerative Colitis (UC) treatment market is already undergoing radical change as new, safer products that slow disease progression have come to market or will be launched in the next few years. While 5-ASA and corticosteroids will remain the backbone of treatment, new products that delay progression ...

Industries: Pathology | Countries: United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.